{"success":true,"data":{"pressRelease":{"id":"165897","rtpr_id":"nPn45BdW1a-20261011","ticker":"PCRX","exchange":"NASDAQ","all_tickers":["PCRX"],"title":"SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX)","author":"PR Newswire","published_at":"2026-10-11T16:30:00.081Z","article_body":"SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX)\nPR Newswire\n\nNEW YORK, Oct. 11, 2026\n\nNEW YORK, Oct. 11, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=1551086027&u=https%3A%2F%2Fmonteverdelaw.com%2Fjuan-e-monteverde%2F&a=Juan+Monteverde)\nwith Monteverde & Associates PC\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=1599623023&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=Monteverde+%26+Associates+PC)\n (the \"M&A Class Action Firm\"), has recovered millions of dollars for\nshareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities\nClass Action Services Report. The firm is headquartered at the Empire State\nBuilding in New York City and is investigating Pacira BioSciences, Inc.\n(NASDAQ: PCRX\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=985650520&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FPCRX%2F&a=PCRX)\n) related to its sale to Viatris Inc. Under the terms of the proposed\ntransaction, Pacira shareholders are expected to receive $36.50 in cash per\nshare. Is it a fair deal?\n\nClick here for more\ninfo https://monteverdelaw.com/case/pacira-biosciences-inc/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=801793656&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fpacira-biosciences-inc%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fpacira-biosciences-inc%2F)\n. It is free and there is no cost or obligation to you.\n\nNOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a\nlawyer and ask:\n\n1. Do you file class actions and go to Court?\n2. When was the last time you recovered money for shareholders?\n3. What cases did you recover money in and how much?\n\nAbout Monteverde & Associates PC\n\nOur firm litigates and has recovered money for shareholders...and we do it\nfrom our offices in the Empire State Building. We are a national class action\nsecurities firm with a successful track record in trial and appellate courts,\nincluding the U.S. Supreme Court.\n\nNo one is above the law. If you own common stock in the above listed company\nand have concerns or wish to obtain additional information free of charge,\nplease visit our website\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=2233706838&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=website)\n or contact Juan Monteverde, Esq. either via e-mail at\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)  or by\ntelephone at (212) 971-1341.\n\nContact:\nJuan Monteverde, Esq.\nMONTEVERDE & ASSOCIATES PC\nThe Empire State Building\n350 Fifth Ave. Suite 4740\nNew York, NY 10118\nUnited States of America\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)\nTel: (212) 971-1341\n\nAttorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm\nresponsible for this advertisement is Monteverde & Associates PC\n(www.monteverdelaw.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=509434426&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=www.monteverdelaw.com)\n). Prior results do not guarantee a similar outcome with respect to any future\nmatter.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-pacira-biosciences-inc-nasdaq-pcrx-302905162.html\n(https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-pacira-biosciences-inc-nasdaq-pcrx-302905162.html)\n\nSOURCE Monteverde & Associates PC\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS753151/Monteverde-Associates-PC-Logo.jpg?id=OA3010662\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn45BdW1a-20261011","title":"SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX)","author":"PR Newswire","ticker":"PCRX","created":"2026-10-11T16:30:00.081Z","tickers":["PCRX"],"exchange":"NASDAQ","article_body":"SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX)\nPR Newswire\n\nNEW YORK, Oct. 11, 2026\n\nNEW YORK, Oct. 11, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=1551086027&u=https%3A%2F%2Fmonteverdelaw.com%2Fjuan-e-monteverde%2F&a=Juan+Monteverde)\nwith Monteverde & Associates PC\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=1599623023&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=Monteverde+%26+Associates+PC)\n (the \"M&A Class Action Firm\"), has recovered millions of dollars for\nshareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities\nClass Action Services Report. The firm is headquartered at the Empire State\nBuilding in New York City and is investigating Pacira BioSciences, Inc.\n(NASDAQ: PCRX\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=985650520&u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FPCRX%2F&a=PCRX)\n) related to its sale to Viatris Inc. Under the terms of the proposed\ntransaction, Pacira shareholders are expected to receive $36.50 in cash per\nshare. Is it a fair deal?\n\nClick here for more\ninfo https://monteverdelaw.com/case/pacira-biosciences-inc/\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=801793656&u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fpacira-biosciences-inc%2F&a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fpacira-biosciences-inc%2F)\n. It is free and there is no cost or obligation to you.\n\nNOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a\nlawyer and ask:\n\n1. Do you file class actions and go to Court?\n2. When was the last time you recovered money for shareholders?\n3. What cases did you recover money in and how much?\n\nAbout Monteverde & Associates PC\n\nOur firm litigates and has recovered money for shareholders...and we do it\nfrom our offices in the Empire State Building. We are a national class action\nsecurities firm with a successful track record in trial and appellate courts,\nincluding the U.S. Supreme Court.\n\nNo one is above the law. If you own common stock in the above listed company\nand have concerns or wish to obtain additional information free of charge,\nplease visit our website\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=2233706838&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=website)\n or contact Juan Monteverde, Esq. either via e-mail at\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)  or by\ntelephone at (212) 971-1341.\n\nContact:\nJuan Monteverde, Esq.\nMONTEVERDE & ASSOCIATES PC\nThe Empire State Building\n350 Fifth Ave. Suite 4740\nNew York, NY 10118\nUnited States of America\njmonteverde@monteverdelaw.com (mailto:jmonteverde@monteverdelaw.com)\nTel: (212) 971-1341\n\nAttorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm\nresponsible for this advertisement is Monteverde & Associates PC\n(www.monteverdelaw.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4795203-1&h=509434426&u=https%3A%2F%2Fmonteverdelaw.com%2F&a=www.monteverdelaw.com)\n). Prior results do not guarantee a similar outcome with respect to any future\nmatter.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-pacira-biosciences-inc-nasdaq-pcrx-302905162.html\n(https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-pacira-biosciences-inc-nasdaq-pcrx-302905162.html)\n\nSOURCE Monteverde & Associates PC\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS753151/Monteverde-Associates-PC-Logo.jpg?id=OA3010662\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-11T16:30:00.123854858Z","server_sent_at_ms":1791736200123},"received_at":"2026-10-11T16:30:00.184Z","source_url":"https://www.prnewswire.com/news-releases/shareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-pacira-biosciences-inc-nasdaq-pcrx-302905162.html"},"analysis":{"id":"154280","press_release_id":"165897","analysis_json":{"industry":{"label":"Pharmaceuticals","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Monteverde & Associates PC announced it is investigating Pacira BioSciences related to its proposed sale to Viatris Inc.\n\nUnder the proposed transaction, Pacira shareholders are expected to receive $36.50 in cash per share, and the firm is questioning whether the deal price is fair.\n\nThis is a routine law-firm solicitation tied to the pending merger, not a new issuer disclosure or court action.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine plaintiff-firm merger probe -- suppress; underlying PCRX/Viatris deal is the real story."},"keyFigures":{"dealValueUsd":0,"customDimensions":{"per_share_consideration":"$36.50 in cash per share"}},"namedEntities":{"people":[{"name":"Juan Monteverde","role":"Class action attorney, Monteverde & Associates PC"}],"products":[],"companies":[{"name":"Monteverde & Associates PC","relationship":"plaintiff law firm"},{"name":"Pacira BioSciences, Inc.","ticker":"PCRX","relationship":"target of investigation"},{"name":"Viatris Inc.","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$36.50","context":"cash per share expected by Pacira shareholders in proposed sale to Viatris"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm (Monteverde & Associates) solicitation investigating the Pacira/Viatris merger consideration; no new issuer disclosure, no certified class, no settlement."},"tickerRelevance":{"others":[],"primary":"PCRX"},"globalImportance":15,"audienceRelevance":25,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"law-firm-merger-solicitation","issuerAuthored":false,"pendingMAContext":true}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Monteverde & Associates PC announced it is investigating Pacira BioSciences related to its proposed sale to Viatris Inc.\n\nUnder the proposed transaction, Pacira shareholders are expected to receive $36.50 in cash per share, and the firm is questioning whether the deal price is fair.\n\nThis is a routine law-firm solicitation tied to the pending merger, not a new issuer disclosure or court action.","key_figures":{"dealValueUsd":0,"customDimensions":{"per_share_consideration":"$36.50 in cash per share"}},"named_entities":{"people":[{"name":"Juan Monteverde","role":"Class action attorney, Monteverde & Associates PC"}],"products":[],"companies":[{"name":"Monteverde & Associates PC","relationship":"plaintiff law firm"},{"name":"Pacira BioSciences, Inc.","ticker":"PCRX","relationship":"target of investigation"},{"name":"Viatris Inc.","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$36.50","context":"cash per share expected by Pacira shareholders in proposed sale to Viatris"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-11T16:30:04.206Z","global_importance":15,"audience_relevance":25,"importance_components":{"tickerTier":"mid-cap","eventGravity":"law-firm-merger-solicitation","issuerAuthored":false,"pendingMAContext":true}},"durationMs":3993,"modelName":"glm-5.3-flashx"}}